This algorithm for the comprehensive management of dyslipidemia and prevention of cardiovascular disease (CVD) complements the 2017 American Association of Clinical Endocrinologists/American College of Endocrinology (AACE/ACE) Guidelines for Management of Dyslipidemia and Prevention of Cardiovascular Disease and provides clinicians with a practical guide that considers the whole patient, their spectrum of risks and complications, and evidence-based approaches to treatment.
Lipids and CV Health Resource Center
Offering Guidance through the Latest Science on Lipid Conditions
This resource center includes presentations that provide guidance on screening, risk assessment and treatment recommendations for a range of individuals with various lipid disorders. The recommendations emphasize the importance of treating low-density lipoprotein cholesterol (LDL-C) in some individuals to lower goals than previously endorsed and support the measurement of coronary artery calcium scores and inflammatory markers to help stratify risk. Special consideration is given to individuals with diabetes, familial hypercholesterolemia, women and youth with dyslipidemia. Both clinical and cost-effectiveness data are provided to support treatment decisions.
